SANDRA LENGUYEN: Open Payments
NPI 1891147898 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 52 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $320 |
| Janssen Biotech, Inc. | 9 | $199 |
| Incyte Corporation | 19 | $176 |
| ABBVIE INC. | 3 | $62 |
| Lilly USA, LLC | 3 | $62 |
| UCB, Inc. | 2 | $38 |
| Organon LLC | 1 | $24 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
Products named: TREMFYA, OPZELURA, Rhapsido, COSENTYX, TALTZ, Bimzelx, SKYRIZI, RINVOQ.
Industry payments across NM — which companies pay providers there.
